Q1 2026 earnings call recap: guidance cut on Middle East headwinds, ddPCR/QX700 momentum, margins & FCF outlook—read key takeaways.

Bio-Rad Laboratories lowered its 2026 revenue growth outlook to between -3% and +0.5% due to Middle East disruptions, while Amgen raised its full-year revenue and EPS guidance on strong product ...

Dpcr Market To Surpass US$14.34 Billion By 2031, Propelled By Escalating Demand For High‐Precision Genetic Analysis - New Industry Research By The Insight Partners.. Growing demand for sensitive and ...

This valuable study reports that the ALDH-abundant cells display stem cell properties and may play a key role in the endometrial epithelial development in the mouse. The data supporting the main ...

The closest-ever detailed look at a key enzyme inside the virus that causes COVID-19 could lead to more effective treatment ...

QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology ...

These findings are important because they suggest that more selective JAK inhibition, particularly targeting JAK1 or JAK2, can effectively reduce organ pathology and pathogenic IFN-γ-producing immune ...

Apple earnings triggered a broad technology rally across major US indices; Software and AI-driven companies led sector ...

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life ...

U.S. equities extended their record run on Friday as Apple Inc.’s AAPL blowout second-quarter earnings powered a broad-based ...

April delivered another dose of pressure for the ASX healthcare sector, with the S&P/ASX 200 Healthcare Index falling 8.67% ...

Advances in cell and molecular biology have catapulted our understanding of the science of life from the basic understanding of how cells and the components of cells interact within living organisms.